UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This article outlines typical volatile periods for SP 500 and how retirees can position portfolios to endure drawdowns while meeting needs.
26,423 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
IBM rallied today on a blend of solid earnings, growing cloud demand, and quantum computing momentum backed by govern...
AMD surged about 5% in early trading, leading a broad chip rally as investors weigh AI infrastructure bets against pe...
The first-quarter earnings season is more than a quarterly ritual. It’s a blueprint for 2026, showing how AI investme...
Lemonade has chased rapid growth, but the real investment signal is in its loss ratio. This article explains why lemo...
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Quantum computing is moving from lab curiosity to market-moving potential. This guide explains why prediction: quantu...
The U.S. IPO market is rekindling activity in 2026, with more offerings and steadier early trading as investors weigh...
A recall at Aldi impacts 500k packages macaroni cheese after soy lecithin was left undeclared on labels. Consumers sh...
ADA sinks toward its latest lows as the broader crypto sell-off deepens. With Hoskinson’s cautions and liquidity fadi...
As the quarter winds down, Monday’s best Wall Street calls set the tone, spotlighting tech, energy and consumer names...
A veteran observer warns that AI's impact extends beyond jobs, threatening cultural norms and household finances. The...